- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06678750
A Prospective Clinical Study Evaluating the Newton™ TKA Protocol
October 14, 2025 updated by: Christopher M. Melnic, MD, Newton-Wellesley Hospital
Evaluation of Clinical Outcomes and Patient Recovery in Patients Receiving TKA With Traditional Instrumentation Systems Compared to Full Arc of Motion Gap Balancing Using the Newton™ Knee Protocol: A Prospective Clinical Study
Evaluation of clinical outcomes and patient recovery in patients receiving TKA with traditional instrumentation systems compared to full arc of motion gap balancing using the Newton TM Knee Protocol
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to evaluate patient outcomes, recovery, and patient/surgeon satisfaction of individuals who undergo a total knee arthroplasty (TKA) using mechanical instrumentation (non-navigated) compared to individuals who undergo a TKA with a tibia first gap balancing surgical workflow using the NewtonTM Knee Protocol and navigation-assistance (ExachtechGPS®).
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Newton, Massachusetts, United States, 02468
- Kaplan Joint Center, Newton Wellesley Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients of Kaplan Joint Center, Newton Wellesley Hospital scheduled for TKA with a specific implant
Exclusion Criteria:
- Patients may be excluded due to some medical conditions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Comparison Group: TKA patients whose surgery was conducted with traditional, manual instrumentation
The comparison groups includes TKA patients whose surgery is conducted using traditional, manual, non-navigated instrumentation.
|
TKA using manual instrumentation
|
|
Experimental: Intervention Group: Patients whose TKA surgery was conducted using Exactech GPS navigation
The intervention group will include TKA patients whose surgery is conducted with a tibia first gap balancing surgical workflow using the NewtonTM Knee Protocol and navigation-assistance (ExachtechGPS®).
|
TKA using Exactech GPS Newton Knee protocol
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction with TKA using patient reported KOOS JR Questionnaire
Time Frame: Pre-op, 4 weeks post-op, 12 weeks post-op, one year post-op
|
The KOOS, JR combines the pain, symptoms, and functional limitations into a single score.
|
Pre-op, 4 weeks post-op, 12 weeks post-op, one year post-op
|
|
Patient satisfaction with TKA using Oxford Knee Score (OKS) Questionnaire
Time Frame: Pre-op, 4 weeks post-op, 12 weeks post-op, one year post-op
|
The OKS is a patient reported questionnaire that measures function and pain with a single score.
|
Pre-op, 4 weeks post-op, 12 weeks post-op, one year post-op
|
|
Patient satisfaction with TKA using Forgotten Joint Score (FJS) Questionnaire
Time Frame: Pre-op, 4 weeks post-op, 12 weeks post-op, one year post-op
|
The Forgotten Joint Score assesses the ability of the patient to forget about their joint given successful treatment by assigning a single score to a series of questions.
|
Pre-op, 4 weeks post-op, 12 weeks post-op, one year post-op
|
|
Patient recovery from TKA using time from hospital stay to discharge
Time Frame: Post-op measure in hours
|
The time of in-patient hospital stay will be measured (in hours).
|
Post-op measure in hours
|
|
Patient recovery from TKA by measuring number of outpatient visits
Time Frame: One year post-op
|
Number of outpatient visits (scheduled and unscheduled)
|
One year post-op
|
|
Patient recovery from TKA by measuring number of PT visits
Time Frame: One year post-op
|
Number of post-op PT visits
|
One year post-op
|
|
Patient recovery from TKA by measuring medication consumption
Time Frame: One year post-op
|
Post-op, prescription medication will be recorded in number of pills and dosage
|
One year post-op
|
|
Patient recovery from TKA by measuring use of assisted walking devices
Time Frame: One year post-op
|
Patient recovery from TKA by measuring the number of days using an assisted walking device following surgery.
|
One year post-op
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee alignment and soft tissue balance
Time Frame: Pre-op, 4 weeks post-op, 12 weeks post-op, one year post-op
|
Telemetric x-rays will be used to assess the angles and evaluate the joint line status pre- and post-operatively.
|
Pre-op, 4 weeks post-op, 12 weeks post-op, one year post-op
|
|
Knee alignment and soft tissue balance
Time Frame: One time (during surgery)
|
Patients receiving a TKA NewtonTM Knee, soft-tissue balance will be measured intra-operatively by placing the Newton distractor at the trial reduction stage and acquiring the corresponding joint laxities through the arc of motion.
|
One time (during surgery)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2024
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Study Registration Dates
First Submitted
October 30, 2024
First Submitted That Met QC Criteria
November 6, 2024
First Posted (Actual)
November 7, 2024
Study Record Updates
Last Update Posted (Actual)
October 20, 2025
Last Update Submitted That Met QC Criteria
October 14, 2025
Last Verified
October 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2024p002323
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.